Research workbench

Structure of human transthyretin ASP38ALA mutant in complex with tafamidis

Analyse Structure of human transthyretin ASP38ALA mutant in complex with tafamidis in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB: 6E77
Type: protein
Length: 230 residues
Chains: 2
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Transthyretin
UniProt: P02766
Ligands: 3MI
Pockets: 2 · best druggability 0.32

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 55% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A, B	Transthyretin	protein	115	6% helix, 55% strand	P02766

Ligands and binding sites

3MI · 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	61	0.32	0.76	13	empty
2	61	0.31	0.75	17	empty

Interfaces

1 interface between chains.

A–B · 936 Å² buried · 21 hydrogen bonds · protein-protein

Compared structures

6E77 · Structure of Human Transthyretin Asp38Ala Mutant in Complex with Tafamidis · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt P02766
Elsewhere: RCSB PDB 6E77 · PDBe 6E77 · UniProt P02766

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.